Biotechnology Market in US 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	170 Pages	TechNavio	January, 2025	INF19584780

Best Price Guarantee
Price	from $2,500
Length	170 Pages
Publisher	TechNavio
Published Date	January, 2025
SKU	INF19584780

Biotechnology Market In US 2025-2029

The biotechnology market in us is forecasted to grow by USD 295.3 bn during 2024-2029, accelerating at a CAGR of 11.5% during the forecast period. The report on the biotechnology market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic and rare diseases, aging population and rising healthcare needs, and government support and funding.

Technavio's biotechnology market in us is segmented as below:

By Product

Biologics
Therapeutics
Diagnostics
Industrial biotechnology
Others

By Type

Red biotechnology
White biotechnology
Green biotechnology
Grey biotechnology
Others

By Geographical Landscape

North America

This study identifies the incorporation of artificial intelligence and machine learning as one of the prime reasons driving the biotechnology market in us growth during the next few years. Also, strategic partnerships and collaborations and shift towards personalized and precision medicine will lead to sizable demand in the market.

The report on the biotechnology market in us covers the following areas:

Biotechnology Market in US sizing
Biotechnology Market in US forecast
Biotechnology Market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biotechnology market in us vendors that include AbbVie Inc., Amgen Inc., Biogen Inc., BioMarin Pharmaceutical Inc., bluebird bio Inc., Eli Lilly and Co., Genentech Inc., Gilead Sciences Inc., Illumina Inc., Johnson and Johnson Inc., Moderna Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sarepta Therapeutics Inc., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc.. Also, the biotechnology market in us analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US: Year-over-year growth 2024-2029 (%); Data Table on US: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Biotechnology Market in US 2019 - 2023; Historic Market Size - Data Table on Biotechnology Market in US 2019 - 2023 ($ billion); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ billion); 5.3 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI on Biotechnology Market in US
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Biologics - Market size and forecast 2024-2029; Chart on Biologics - Market size and forecast 2024-2029 ($ billion); Data Table on Biologics - Market size and forecast 2024-2029 ($ billion); Chart on Biologics - Year-over-year growth 2024-2029 (%); Data Table on Biologics - Year-over-year growth 2024-2029 (%); 8.4 Therapeutics - Market size and forecast 2024-2029; Chart on Therapeutics - Market size and forecast 2024-2029 ($ billion); Data Table on Therapeutics - Market size and forecast 2024-2029 ($ billion); Chart on Therapeutics - Year-over-year growth 2024-2029 (%); Data Table on Therapeutics - Year-over-year growth 2024-2029 (%); 8.5 Diagnostics - Market size and forecast 2024-2029; Chart on Diagnostics - Market size and forecast 2024-2029 ($ billion); Data Table on Diagnostics - Market size and forecast 2024-2029 ($ billion); Chart on Diagnostics - Year-over-year growth 2024-2029 (%); Data Table on Diagnostics - Year-over-year growth 2024-2029 (%); 8.6 Industrial biotechnology - Market size and forecast 2024-2029; Chart on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on Industrial biotechnology - Year-over-year growth 2024-2029 (%); Data Table on Industrial biotechnology - Year-over-year growth 2024-2029 (%); 8.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.8 Market opportunity by Product; Market opportunity by Product ($ billion); Data Table on Market opportunity by Product ($ billion)
9 Market Segmentation by Type: 9.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 9.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 9.3 Red biotechnology - Market size and forecast 2024-2029; Chart on Red biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on Red biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on Red biotechnology - Year-over-year growth 2024-2029 (%); Data Table on Red biotechnology - Year-over-year growth 2024-2029 (%); 9.4 White biotechnology - Market size and forecast 2024-2029; Chart on White biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on White biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on White biotechnology - Year-over-year growth 2024-2029 (%); Data Table on White biotechnology - Year-over-year growth 2024-2029 (%); 9.5 Green biotechnology - Market size and forecast 2024-2029; Chart on Green biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on Green biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on Green biotechnology - Year-over-year growth 2024-2029 (%); Data Table on Green biotechnology - Year-over-year growth 2024-2029 (%); 9.6 Grey biotechnology - Market size and forecast 2024-2029; Chart on Grey biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on Grey biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on Grey biotechnology - Year-over-year growth 2024-2029 (%); Data Table on Grey biotechnology - Year-over-year growth 2024-2029 (%); 9.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.8 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Drivers, Challenges, and Opportunity/Restraints: 11.1 Market drivers; 11.2 Market challenges; 11.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 11.4 Market opportunities/restraints
12 Competitive Landscape: 12.1 Overview; 12.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 12.3 Landscape disruption; Overview on factors of disruption; 12.4 Industry risks; Impact of key risks on business
13 Competitive Analysis: 13.1 Companies profiled; Companies covered; 13.2 Company ranking index; Company ranking index; 13.3 Market positioning of companies; Matrix on companies position and classification; 13.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 13.5 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 13.6 Biogen Inc.; Biogen Inc. - Overview; Biogen Inc. - Product / Service; Biogen Inc. - Key news; Biogen Inc. - Key offerings; SWOT; 13.7 BioMarin Pharmaceutical Inc.; BioMarin Pharmaceutical Inc. - Overview; BioMarin Pharmaceutical Inc. - Product / Service; BioMarin Pharmaceutical Inc. - Key offerings; SWOT; 13.8 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key offerings; SWOT; 13.9 Genentech Inc.; Genentech Inc. - Overview; Genentech Inc. - Product / Service; Genentech Inc. - Key offerings; SWOT; 13.10 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; SWOT; 13.11 Illumina Inc.; Illumina Inc. - Overview; Illumina Inc. - Business segments; Illumina Inc. - Key news; Illumina Inc. - Key offerings; Illumina Inc. - Segment focus; SWOT; 13.12 Johnson and Johnson Inc.; Johnson and Johnson Inc. - Overview; Johnson and Johnson Inc. - Business segments; Johnson and Johnson Inc. - Key news; Johnson and Johnson Inc. - Key offerings; Johnson and Johnson Inc. - Segment focus; SWOT; 13.13 Moderna Inc.; Moderna Inc. - Overview; Moderna Inc. - Product / Service; Moderna Inc. - Key offerings; SWOT; 13.14 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 13.15 Regeneron Pharmaceuticals Inc.; Regeneron Pharmaceuticals Inc. - Overview; Regeneron Pharmaceuticals Inc. - Product / Service; Regeneron Pharmaceuticals Inc. - Key offerings; SWOT; 13.16 Sarepta Therapeutics Inc.; Sarepta Therapeutics Inc. - Overview; Sarepta Therapeutics Inc. - Product / Service; Sarepta Therapeutics Inc. - Key offerings; SWOT; 13.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus; SWOT; 13.18 Vertex Pharmaceuticals Inc.; Vertex Pharmaceuticals Inc. - Overview; Vertex Pharmaceuticals Inc. - Product / Service; Vertex Pharmaceuticals Inc. - Key offerings; SWOT
14 Appendix: 14.1 Scope of the report; 14.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 14.3 Currency conversion rates for US$; Currency conversion rates for US$; 14.4 Research methodology; Research methodology; 14.5 Data procurement; Information sources; 14.6 Data validation; Data validation; 14.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 14.8 Data synthesis; Data synthesis; 14.9 360 degree market analysis; 360 degree market analysis; 14.10 List of abbreviations; List of abbreviations; o Strong market position; o Enhancement of alliances and partnerships; o Strong geographic presence; o Strong operational management; o Strong geographic presence; o Strong operational management; o Enhancement of alliances and partnerships; o Strong market position; o Strong operational management; o Strong infrastructure base; o Strong market position; o Strong infrastructure base; o Growing demand for the market; o Strong geographic presence; o Strong market position; o Capacity expansion of the market; o Strong operational management; o Strong geographic presence; o Expansion of service business; o Strong infrastructure base
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Product; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Company Market Positioning; Exhibits7: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits8: Overview on criticality of inputs and factors of differentiation; Exhibits9: Overview on factors of disruption; Exhibits10: Impact of drivers and challenges in 2024 and 2029; Exhibits11: Parent Market; Exhibits12: Data Table on - Parent Market; Exhibits13: Market characteristics analysis; Exhibits14: Value chain analysis; Exhibits15: Offerings of companies included in the market definition; Exhibits16: Market segments; Exhibits17: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits18: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits19: Chart on US: Year-over-year growth 2024-2029 (%); Exhibits20: Data Table on US: Year-over-year growth 2024-2029 (%); Exhibits21: Historic Market Size - Data Table on Biotechnology Market in US 2019 - 2023 ($ billion); Exhibits22: Historic Market Size - Product Segment 2019 - 2023 ($ billion); Exhibits23: Historic Market Size - Type Segment 2019 - 2023 ($ billion); Exhibits24: Five forces analysis - Comparison between 2024 and 2029; Exhibits25: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits26: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits27: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits28: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits29: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits30: Chart on Market condition - Five forces 2024 and 2029; Exhibits31: Chart on Product - Market share 2024-2029 (%); Exhibits32: Data Table on Product - Market share 2024-2029 (%); Exhibits33: Chart on Comparison by Product; Exhibits34: Data Table on Comparison by Product; Exhibits35: Chart on Biologics - Market size and forecast 2024-2029 ($ billion); Exhibits36: Data Table on Biologics - Market size and forecast 2024-2029 ($ billion); Exhibits37: Chart on Biologics - Year-over-year growth 2024-2029 (%); Exhibits38: Data Table on Biologics - Year-over-year growth 2024-2029 (%); Exhibits39: Chart on Therapeutics - Market size and forecast 2024-2029 ($ billion); Exhibits40: Data Table on Therapeutics - Market size and forecast 2024-2029 ($ billion); Exhibits41: Chart on Therapeutics - Year-over-year growth 2024-2029 (%); Exhibits42: Data Table on Therapeutics - Year-over-year growth 2024-2029 (%); Exhibits43: Chart on Diagnostics - Market size and forecast 2024-2029 ($ billion); Exhibits44: Data Table on Diagnostics - Market size and forecast 2024-2029 ($ billion); Exhibits45: Chart on Diagnostics - Year-over-year growth 2024-2029 (%); Exhibits46: Data Table on Diagnostics - Year-over-year growth 2024-2029 (%); Exhibits47: Chart on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits48: Data Table on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits49: Chart on Industrial biotechnology - Year-over-year growth 2024-2029 (%); Exhibits50: Data Table on Industrial biotechnology - Year-over-year growth 2024-2029 (%); Exhibits51: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits52: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits53: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits54: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits55: Market opportunity by Product ($ billion); Exhibits56: Data Table on Market opportunity by Product ($ billion); Exhibits57: Chart on Type - Market share 2024-2029 (%); Exhibits58: Data Table on Type - Market share 2024-2029 (%); Exhibits59: Chart on Comparison by Type; Exhibits60: Data Table on Comparison by Type; Exhibits61: Chart on Red biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits62: Data Table on Red biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits63: Chart on Red biotechnology - Year-over-year growth 2024-2029 (%); Exhibits64: Data Table on Red biotechnology - Year-over-year growth 2024-2029 (%); Exhibits65: Chart on White biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits66: Data Table on White biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits67: Chart on White biotechnology - Year-over-year growth 2024-2029 (%); Exhibits68: Data Table on White biotechnology - Year-over-year growth 2024-2029 (%); Exhibits69: Chart on Green biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits70: Data Table on Green biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits71: Chart on Green biotechnology - Year-over-year growth 2024-2029 (%); Exhibits72: Data Table on Green biotechnology - Year-over-year growth 2024-2029 (%); Exhibits73: Chart on Grey biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits74: Data Table on Grey biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits75: Chart on Grey biotechnology - Year-over-year growth 2024-2029 (%); Exhibits76: Data Table on Grey biotechnology - Year-over-year growth 2024-2029 (%); Exhibits77: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits78: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits79: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits80: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits81: Market opportunity by Type ($ billion); Exhibits82: Data Table on Market opportunity by Type ($ billion); Exhibits83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits84: Impact of drivers and challenges in 2024 and 2029; Exhibits85: Overview on criticality of inputs and factors of differentiation; Exhibits86: Overview on factors of disruption; Exhibits87: Impact of key risks on business; Exhibits88: Companies covered; Exhibits89: Company ranking index; Exhibits90: Matrix on companies position and classification; Exhibits91: AbbVie Inc. - Overview; Exhibits92: AbbVie Inc. - Product / Service; Exhibits93: AbbVie Inc. - Key news; Exhibits94: AbbVie Inc. - Key offerings; Exhibits95: SWOT; Exhibits96: Amgen Inc. - Overview; Exhibits97: Amgen Inc. - Product / Service; Exhibits98: Amgen Inc. - Key news; Exhibits99: Amgen Inc. - Key offerings; Exhibits100: SWOT; Exhibits101: Biogen Inc. - Overview; Exhibits102: Biogen Inc. - Product / Service; Exhibits103: Biogen Inc. - Key news; Exhibits104: Biogen Inc. - Key offerings; Exhibits105: SWOT; Exhibits106: BioMarin Pharmaceutical Inc. - Overview; Exhibits107: BioMarin Pharmaceutical Inc. - Product / Service; Exhibits108: BioMarin Pharmaceutical Inc. - Key offerings; Exhibits109: SWOT; Exhibits110: Eli Lilly and Co. - Overview; Exhibits111: Eli Lilly and Co. - Product / Service; Exhibits112: Eli Lilly and Co. - Key offerings; Exhibits113: SWOT; Exhibits114: Genentech Inc. - Overview; Exhibits115: Genentech Inc. - Product / Service; Exhibits116: Genentech Inc. - Key offerings; Exhibits117: SWOT; Exhibits118: Gilead Sciences Inc. - Overview; Exhibits119: Gilead Sciences Inc. - Product / Service; Exhibits120: Gilead Sciences Inc. - Key news; Exhibits121: Gilead Sciences Inc. - Key offerings; Exhibits122: SWOT; Exhibits123: Illumina Inc. - Overview; Exhibits124: Illumina Inc. - Business segments; Exhibits125: Illumina Inc. - Key news; Exhibits126: Illumina Inc. - Key offerings; Exhibits127: Illumina Inc. - Segment focus; Exhibits128: SWOT; Exhibits129: Johnson and Johnson Inc. - Overview; Exhibits130: Johnson and Johnson Inc. - Business segments; Exhibits131: Johnson and Johnson Inc. - Key news; Exhibits132: Johnson and Johnson Inc. - Key offerings; Exhibits133: Johnson and Johnson Inc. - Segment focus; Exhibits134: SWOT; Exhibits135: Moderna Inc. - Overview; Exhibits136: Moderna Inc. - Product / Service; Exhibits137: Moderna Inc. - Key offerings; Exhibits138: SWOT; Exhibits139: Pfizer Inc. - Overview; Exhibits140: Pfizer Inc. - Product / Service; Exhibits141: Pfizer Inc. - Key news; Exhibits142: Pfizer Inc. - Key offerings; Exhibits143: SWOT; Exhibits144: Regeneron Pharmaceuticals Inc. - Overview; Exhibits145: Regeneron Pharmaceuticals Inc. - Product / Service; Exhibits146: Regeneron Pharmaceuticals Inc. - Key offerings; Exhibits147: SWOT; Exhibits148: Sarepta Therapeutics Inc. - Overview; Exhibits149: Sarepta Therapeutics Inc. - Product / Service; Exhibits150: Sarepta Therapeutics Inc. - Key offerings; Exhibits151: SWOT; Exhibits152: Thermo Fisher Scientific Inc. - Overview; Exhibits153: Thermo Fisher Scientific Inc. - Business segments; Exhibits154: Thermo Fisher Scientific Inc. - Key news; Exhibits155: Thermo Fisher Scientific Inc. - Key offerings; Exhibits156: Thermo Fisher Scientific Inc. - Segment focus; Exhibits157: SWOT; Exhibits158: Vertex Pharmaceuticals Inc. - Overview; Exhibits159: Vertex Pharmaceuticals Inc. - Product / Service; Exhibits160: Vertex Pharmaceuticals Inc. - Key offerings; Exhibits161: SWOT; Exhibits162: Inclusions checklist; Exhibits163: Exclusions checklist; Exhibits164: Currency conversion rates for US$; Exhibits165: Research methodology; Exhibits166: Information sources; Exhibits167: Data validation; Exhibits168: Validation techniques employed for market sizing; Exhibits169: Data synthesis; Exhibits170: 360 degree market analysis; Exhibits171: List of abbreviations